CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo

1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry

Oxford University Hospitals NHS Foundation Trust Propels Digitisation with PhenoTips’ Genomic Health Record.

Oxford University Hospitals NHS Foundation Trust (OUH) accelerates their Digital by Default strategy by harnessing PhenoTips’ cloud-hosted Genomic Health Record to digitise, integrate, and standardise genomic care.

Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities

Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).

PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS

PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Laudio Insights Releases “Leader Inspired Work” to Empower Healthcare’s Critical Frontline Leaders

Exothera announced the appointment of Cedric Volanti as CEO

Exothera has announced the appointment of a new CEO, Cédric Volanti.

Pii Introduces Accelevate™ Early Development Platform, Enabling IND Submissions in 100 Days for Aseptic Products

New Platform Reduces IND Submission Timelines for Small and Mid-Sized Pharma Companies.

Synexa Life Sciences Expands Bioanalysis Capabilities with the Acquisition of CRO Alderley Analytical

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, reflecting an important milestone in Synexa’s ‘buy and build’ growth strategy. By combining the two complementary companies, the group can now offer an even more comprehensive range of services to an enlarged customer base, both in large and small molecule drug development, and ranging from pre-clinical work to phase III clinical studies.

Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns

Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice

Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision.

Certara Completes Acquisition of Chemaxon

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization.

Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.

CAI Appoints Sheena Dempsey as Chief Executive Officer

Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity

MATTER launches first Paratus Digital Health Hub Readiness Accelerator as part of BARDA Accelerator Network

The accelerator seeks next-generation digital health solutions supporting preparedness and response to health security threats

Zymo Research & BluMaiden Biosciences Announce Partnership to Provide Clinical Trial Analytics and Reporting Services to the Pharmaceutical Sector

This press release announces the partnership between Zymo Research and BluMaiden Biosciences to provide end-to-end clinical trial analytics and reporting services based on the human microbiome. We believe this development will be of significant interest to your audience, particularly those working in the pharmaceutical sector. The press release highlights how the new joint service will cover every stage of human microbiome analysis, including fit-for-purpose sample collection, nucleic acid purification, next-generation sequencing, sophisticated bioinformatics data analysis, and detailed clinical trial reporting. This service is designed to be applicable across entire trial cohorts and can be applied to a broad range of disease indications and intervention modalities, making it especially valuable for researchers and professionals in the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Sphere Fluidics has introduced Cyto-Mine Chroma – the second generation of its award-winning, flagship Cyto-Mine single cell analysis and isolation platform. With the upgrade to a four-color laser and detector system, Chroma offers enhanced capabilities to further maximise the efficiency and precision of single-cell functional analysis workflows. By accelerating the early selection of superior candidate cells, it supports project timelines to be reduced from months to weeks, and minimising effort and cost.

Vaxess Receives National Institutes of Health Grant to Explore Administering Type 2 Diabetes Treatment via the MIMIX™ Transdermal Patch Platform

The National Institute of Diabetes and Digestive and Kidney Diseases Awards Vaxess SBIR Phase I Funding to Test Company’s MIMIX Transdermal Patch Platform in Administering GLP-1 RA Therapies